275 related articles for article (PubMed ID: 24427350)
1. Prognostic value of β1 integrin expression in colorectal liver metastases.
Vassos N; Rau T; Merkel S; Feiersinger F; Geppert CI; Stürzl M; Hohenberger W; Croner RS
Int J Clin Exp Pathol; 2014; 7(1):288-300. PubMed ID: 24427350
[TBL] [Abstract][Full Text] [Related]
2. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.
dos Santos PB; Zanetti JS; Ribeiro-Silva A; Beltrão EI
Diagn Pathol; 2012 Aug; 7():104. PubMed ID: 22894137
[TBL] [Abstract][Full Text] [Related]
3. Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
Schweiger T; Nikolowsky C; Starlinger P; Traxler D; Zimmermann M; Birner P; Hegedüs B; Dome B; Bergmann M; Mildner M; Klepetko W; Hoetzenecker K; Ankersmit HJ
PLoS One; 2015; 10(3):e0120724. PubMed ID: 25793600
[TBL] [Abstract][Full Text] [Related]
4. The morphological growth patterns of colorectal liver metastases are prognostic for overall survival.
Nielsen K; Rolff HC; Eefsen RL; Vainer B
Mod Pathol; 2014 Dec; 27(12):1641-8. PubMed ID: 24851832
[TBL] [Abstract][Full Text] [Related]
5. Association of CD98, integrin β1, integrin β3 and Fak with the progression and liver metastases of colorectal cancer.
Sun C; Zargham R; Shao Q; Gui X; Marcus V; Lazaris A; Salman A; Metrakos P; Qu X; Gao Z
Pathol Res Pract; 2014 Oct; 210(10):668-74. PubMed ID: 25041835
[TBL] [Abstract][Full Text] [Related]
6. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y
Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer.
Lin Q; Wei Y; Zhong Y; Zhu D; Ren L; Xu P; Zheng P; Feng Q; Ji M; Lv M; Liang C; Xu J
Tumour Biol; 2014 Oct; 35(10):9743-50. PubMed ID: 24972972
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases.
Chen J; Li Q; Wang C; Wu J; Zhao G
Ann Surg Oncol; 2010 Jun; 17(6):1555-63. PubMed ID: 20069460
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
Goos JA; Hiemstra AC; Coupé VM; Diosdado B; Kooijman W; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ; ;
Br J Cancer; 2014 Aug; 111(4):749-55. PubMed ID: 24983372
[TBL] [Abstract][Full Text] [Related]
10. Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer.
Pérez-Ruiz E; Rueda A; Pérez L; Rivas-Ruiz F; Torres E; de Luque V; Álvarez M; Sevilla I; Redondo M; Padilla-Ruiz M; Alba E; Alonso L
Pathol Oncol Res; 2018 Oct; 24(4):871-879. PubMed ID: 28889324
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
12. Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer.
Dingemans AM; van den Boogaart V; Vosse BA; van Suylen RJ; Griffioen AW; Thijssen VL
Mol Cancer; 2010 Jun; 9():152. PubMed ID: 20565758
[TBL] [Abstract][Full Text] [Related]
13. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
14. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CD133
Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
[TBL] [Abstract][Full Text] [Related]
17. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
[TBL] [Abstract][Full Text] [Related]
18. Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance.
D'Angelica M; Ammori J; Gonen M; Klimstra DS; Low PS; Murphy L; Weiser MR; Paty PB; Fong Y; Dematteo RP; Allen P; Jarnagin WR; Shia J
Mod Pathol; 2011 Sep; 24(9):1221-8. PubMed ID: 21572402
[TBL] [Abstract][Full Text] [Related]
19. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
[TBL] [Abstract][Full Text] [Related]
20. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
